Peter Stegagno - 14 Dec 2017 Form 4 Insider Report for SANUWAVE Health, Inc. (SNWV)

Reporting relationship: Chief Operating Officer
Issuer ticker: SNWV
Reported as of: 14 Dec 2017
Net transaction value: +$0.2655
SEC form: 4
Accepted by SEC: 07 Apr 2025, 16:07:12 UTC
Prior SEC filing: 07 Apr 2025
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Griffin D. Foster as Attorney-in-Fact for Peter Stegagno

Key filing fact

Peter Stegagno filed Form 4 for SANUWAVE Health, Inc. (SNWV) on 07 Apr 2025.

Key facts

This page summarizes Peter Stegagno's Form 4 filing for SANUWAVE Health, Inc. (SNWV).
22 reported transactions and 20 derivative rows are listed below.
Accepted by SEC: 07 Apr 2025, 16:07.

Change

Previous filing in this sequence was filed on 07 Apr 2025.
Current net transaction value: +$0.2655.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SNWV transaction

Common Stock

Award

Transaction value
Shares: +885
Change %: +14750%
Price
Shares after: 891
Date: 29 Aug 2019
Ownership: Direct
Footnotes: F1

SNWV transaction

Common Stock

Award

Transaction value
Shares: +1,141
Change %: +128%
Price
Shares after: 2,032
Date: 29 Aug 2019
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNWV transaction Derivative

Class N Warrant (right to buy)

Award

Transaction value: $0.2655
Shares: +885
Change %
Price: $0.000300
Shares after: 885
Date: 21 Dec 2017
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300

SNWV transaction Derivative

Class N Warrant (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -885
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 23 Jan 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F3

SNWV transaction Derivative

Class N Warrant (right to buy)

Award

Transaction value: $0
Shares: +885
Change %
Price: $0.000000
Shares after: 885
Date: 23 Jan 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F3

SNWV transaction Derivative

Class N Warrant (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -885
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 May 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F4

SNWV transaction Derivative

Class N Warrant (right to buy)

Award

Transaction value: $0
Shares: +885
Change %
Price: $0.000000
Shares after: 885
Date: 01 May 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F4

SNWV transaction Derivative

Class N Warrant (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -885
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 May 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F5

SNWV transaction Derivative

Class N Warrant (right to buy)

Award

Transaction value: $0
Shares: +885
Change %
Price: $0.000000
Shares after: 885
Date: 31 May 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F5

SNWV transaction Derivative

Class N Warrant (right to buy)

Options Exercise

Transaction value: $0
Shares: -885
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 29 Aug 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 885
Exercise price: $0.000300
Footnotes: F1

SNWV transaction Derivative

Class O Warrant (right to buy)

Award

Transaction value: $0
Shares: +1,141
Change %
Price: $0.000000
Shares after: 1,141
Date: 11 Dec 2017
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,141
Exercise price: $0.000300
Footnotes: F6

SNWV transaction Derivative

Class O Warrant (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -1,141
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Mar 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,141
Exercise price: $0.000300
Footnotes: F7

SNWV transaction Derivative

Class O Warrant (right to buy)

Award

Transaction value: $0
Shares: +1,141
Change %
Price: $0.000000
Shares after: 1,141
Date: 01 Mar 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,141
Exercise price: $0.000300
Footnotes: F7

SNWV transaction Derivative

Class O Warrant (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -1,141
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 May 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,141
Exercise price: $0.000300
Footnotes: F8

SNWV transaction Derivative

Class O Warrant (right to buy)

Award

Transaction value: $0
Shares: +1,141
Change %
Price: $0.000000
Shares after: 1,141
Date: 31 May 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,141
Exercise price: $0.000300
Footnotes: F8

SNWV transaction Derivative

Class O Warrant (right to buy)

Options Exercise

Transaction value: $0
Shares: -1,141
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 29 Aug 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,141
Exercise price: $0.000300
Footnotes: F2

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,333
Change %
Price: $0.000000
Shares after: 1,333
Date: 16 Jun 2016
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,333
Exercise price: $15.00
Footnotes: F9

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,132
Change %
Price: $0.000000
Shares after: 1,132
Date: 09 Nov 2016
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,132
Exercise price: $67.50
Footnotes: F9

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,600
Change %
Price: $0.000000
Shares after: 1,600
Date: 15 Jun 2017
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,600
Exercise price: $41.25
Footnotes: F9

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +2,000
Change %
Price: $0.000000
Shares after: 2,000
Date: 20 Sep 2018
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000
Exercise price: $78.75
Footnotes: F9

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +133
Change %
Price: $0.000000
Shares after: 133
Date: 26 Aug 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 133
Exercise price: $56.25
Footnotes: F9

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +40,000
Change %
Price: $0.000000
Shares after: 40,000
Date: 22 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $14.20
Footnotes: F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

On August 29, 2019, the reporting person exercised the Class N Warrants for 885 shares of common stock of Sanuwave Health, Inc. (the "Company") at an exercise price of $0.00029 per share.

Footnote F2

On August 29, 2019, the reporting person exercised the Class O Warrants for 1,141 shares of the Company's common stock at an exercise price of $0.00029 per share.

Footnote F3

On January 23, 2019, the Company extended the expiration date of the Class N Warrants to May 1, 2019.

Footnote F4

On May 1, 2019, the Company extended the expiration date of the Class N Warrants to June 28, 2019.

Footnote F5

On May 31, 2019, the Company extended the expiration date of the Class N Warrants to September 3, 2019.

Footnote F6

On December 11, 2017, the reporting person received Class O Warrants exercisable for 1,141 shares of common stock at an exercise price of $0.00029 per share as compensation.

Footnote F7

On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019.

Footnote F8

On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019.

Footnote F9

Options were fully vested at the grant date.

Footnote F10

Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.

SEC remarks

All share amounts and exercise prices herein have been retroactively adjusted to reflect the 1-for-375 reverse stock split of the Company's common stock which occurred on October 18, 2024.